doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
BPC-157 interactions with growth factor pathways: While specific receptor for BPC-157 remains unidentified, research suggests it modulates VEGF receptor signaling enhancing angiogenesis in ischemic tissues
PubMed evidence trail Research sources used to frame this page For Hims vs Ro vs Calibrate for GLP-1 Weight Loss: 3-Way Price, Medication & Support Comparison (2025), FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
J Korean Med Sci 2008
If you have type 2 diabetes, it is important to monitor your blood sugar especially if youve been prescribed a semaglutide medication for weight loss or to manage diabetes
Tng cng sc khng cho da